Guardian Pharmacy Services (GRDN) Return on Capital Employed (2024 - 2026)

Guardian Pharmacy Services has disclosed Return on Capital Employed across 3 years of filings, most recently posting 29.84% for Q1 2026.

• Return on Capital Employed for Q1 2026 came in at 29.84%, up 6161.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 29.84% (up 6161.0% YoY), and the FY2025 annual result was 35.29%, up 7672.0% from the prior year.
• Return on Capital Employed came in at 29.84% for Q1 2026 at Guardian Pharmacy Services, down from 30.21% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 30.21% in Q4 2025 to a low of 33.06% in Q4 2024.
• The 3-year median for Return on Capital Employed is 1.58% (2025), against an average of 1.32%.
• Across the five-year window, Return on Capital Employed soared 6327 bps in 2025 and soared 6161 bps in 2026, its largest moves.
• Guardian Pharmacy Services' Return on Capital Employed stood at 33.06% in 2024, then surged by 191 bps to 30.21% in 2025, then slipped by 1 bps to 29.84% in 2026.
• The last three Return on Capital Employed figures came in at 29.84% (Q1 2026), 30.21% (Q4 2025), and 27.79% (Q3 2025), per Business Quant data.